121 related articles for article (PubMed ID: 38048725)
1. Wire-guided localization and surgical resection of non-palpable recurrent of thyroid carcinoma: A STROBE-compliant, retrospective cohort study.
Carrillo JF; Carrillo LC; Ramírez-Ortega MC; Pacheco-Bravo I; Ramos-Mayo A; Oñate-Ocaña LF
Eur J Surg Oncol; 2024 Jan; 50(1):107306. PubMed ID: 38048725
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
[TBL] [Abstract][Full Text] [Related]
4. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
[TBL] [Abstract][Full Text] [Related]
5. The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients.
Miah CF; Zaman JA; Simon M; Davidov T; Trooskin SZ
Surgery; 2014 Dec; 156(6):1491-6; discussion 1496-7. PubMed ID: 25456939
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
7. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
8. Neural monitored revision thyroid cancer surgery: surgical safety and thyroglobulin response.
Phelan E; Kamani D; Shin J; Randolph GW
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):47-52. PubMed ID: 23695590
[TBL] [Abstract][Full Text] [Related]
9. Contribution of gamma probe-guided surgery to lateral approach completion thyroidectomy.
Uludag M; Yetkin G; Citgez B; Isgor A; Atay M; Kebudi A; Akgun I
Endocr Pract; 2009 Apr; 15(3):213-9. PubMed ID: 19364688
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive video-assisted thyroidectomy for papillary thyroid cancer: a prospective 5-year follow-up study.
Del Rio P; Maestroni U; Sianesi M; Viani L; Vicente D; Stojadinovic A; Avital I
Tumori; 2015; 101(2):144-7. PubMed ID: 25791536
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the risk of re-recurrence in patients with persistent/recurrent thyroid carcinoma after initial reoperation.
Xu S; Li Q; Wang Z; Huang H; Wang X; Liu S; Liu J
Surgery; 2021 Apr; 169(4):837-843. PubMed ID: 33127094
[TBL] [Abstract][Full Text] [Related]
12. Sonographically-directed neck dissection for recurrent thyroid carcinoma.
Lee L; Steward DL
Laryngoscope; 2008 Jun; 118(6):991-4. PubMed ID: 18401275
[TBL] [Abstract][Full Text] [Related]
13. Long-term oncologic outcome of robotic versus open total thyroidectomy in PTC: a case-matched retrospective study.
Lee SG; Lee J; Kim MJ; Choi JB; Kim TH; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jo YS; Chung WY
Surg Endosc; 2016 Aug; 30(8):3474-9. PubMed ID: 26514137
[TBL] [Abstract][Full Text] [Related]
14. Radioguided occult lesion localization in patients with recurrent thyroid cancer.
Tuncel M; Süslü N
Eur Arch Otorhinolaryngol; 2019 Jun; 276(6):1757-1766. PubMed ID: 30887167
[TBL] [Abstract][Full Text] [Related]
15. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
16. Use of
Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
Akkas BE; Demirel BB; Vural GU
Thyroid; 2014 Feb; 24(2):287-95. PubMed ID: 23750862
[TBL] [Abstract][Full Text] [Related]
18. Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial.
Jammah AA; Masood A; Akkielah LA; Alhaddad S; Alhaddad MA; Alharbi M; Alguwaihes A; Alzahrani S
Front Endocrinol (Lausanne); 2020; 11():603432. PubMed ID: 33716951
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
Dahele M; Ung YC; Ehrlich L; Silverberg J; Balogh J; Wong CS
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
